These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 6193563

  • 21. The effects of antidepressants on the cerebrospinal fluid homovanillic acid/5-hydroxyindoleacetic acid ratio.
    Risby ED, Hsiao JK, Sunderland T, Agren H, Rudorfer MV, Potter WZ.
    Clin Pharmacol Ther; 1987 Nov; 42(5):547-54. PubMed ID: 2445515
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Urinary monoamine metabolites in children with minimal brain dysfunction.
    Wender PH, Epstein RS, Kopin IJ, Gordon EK.
    Am J Psychiatry; 1971 Apr; 127(10):1411-5. PubMed ID: 5549938
    [No Abstract] [Full Text] [Related]

  • 24. Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites.
    Potter WZ, Scheinin M, Golden RN, Rudorfer MV, Cowdry RW, Calil HM, Ross RJ, Linnoila M.
    Arch Gen Psychiatry; 1985 Dec; 42(12):1171-7. PubMed ID: 2416297
    [Abstract] [Full Text] [Related]

  • 25. Cerebrospinal fluid studies of monoamine metabolism in schizophrenia.
    van Kammen DP, Peters J, van Kammen WB.
    Psychiatr Clin North Am; 1986 Mar; 9(1):81-97. PubMed ID: 2421272
    [Abstract] [Full Text] [Related]

  • 26. Neurochemical variables in delusional depression.
    Lykouras E, Markianos M, Malliaras D, Stefanis C.
    Am J Psychiatry; 1988 Feb; 145(2):214-7. PubMed ID: 2449085
    [Abstract] [Full Text] [Related]

  • 27. Disturbance of neurotransmitter metabolism in drug-naïve, first-episode major depressive disorder: a comparative study on adult and adolescent cohorts.
    Wang L, Yang P, Yang C, Yang D, Wu X, Cao T, Zeng C, Chen Q, Zhang S, Zhu Z, Jiao S, Cai H.
    Eur Arch Psychiatry Clin Neurosci; 2022 Oct; 272(7):1283-1296. PubMed ID: 35410391
    [Abstract] [Full Text] [Related]

  • 28. Central neurochemical ultradian variability in depression.
    Salomon RM, Johnson BW, Schmidt DE.
    Dis Markers; 2006 Oct; 22(1-2):65-72. PubMed ID: 16410652
    [Abstract] [Full Text] [Related]

  • 29. Neurotransmitters in the brains of patients with dementia disorders.
    Gottfries CG.
    Dan Med Bull; 1985 Feb; 32 Suppl 1():44-8. PubMed ID: 2580668
    [No Abstract] [Full Text] [Related]

  • 30. Clinical and biochemical heterogeneity of depressive disorders.
    Maas JW.
    Ann Intern Med; 1978 Apr; 88(4):556-63. PubMed ID: 25035
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Shifting depression.
    Campbell IC, Marsden K, Powell JF.
    Psychol Med; 1994 May; 24(2):271-3. PubMed ID: 8084925
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Dystrobrevin-binding protein 1 gene (DTNBP1) variants associated with cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in healthy volunteers.
    Andreou D, Saetre P, Kähler AK, Werge T, Andreassen OA, Agartz I, Sedvall GC, Hall H, Terenius L, Jönsson EG.
    Eur Neuropsychopharmacol; 2011 Sep; 21(9):700-4. PubMed ID: 21295953
    [Abstract] [Full Text] [Related]

  • 36. Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia.
    Roy A, Pickar D, Linnoila M, Doran AR, Ninan P, Paul SM.
    Psychiatry Res; 1985 Aug; 15(4):281-92. PubMed ID: 2415996
    [Abstract] [Full Text] [Related]

  • 37. Biological markers in depression. Monoamine metabolites in urine of depressed patients and normal subjects.
    Vandel S, Vandel B, Bonin B, Camejo Z, Sandoz M, Allers G, Volmat R.
    Pharmacopsychiatry; 1985 Nov; 18(6):347-50. PubMed ID: 2418451
    [Abstract] [Full Text] [Related]

  • 38. Interactions of drugs and electroshock treatment on cerebral monoaminergic systems.
    Barkai AI.
    Ann N Y Acad Sci; 1986 Nov; 462():147-62. PubMed ID: 2423001
    [Abstract] [Full Text] [Related]

  • 39. Recent advances in psychopharmacology of depression.
    Johnson GF.
    Aust N Z J Psychiatry; 1981 Sep; 15(3):223-7. PubMed ID: 6174112
    [No Abstract] [Full Text] [Related]

  • 40. Electroconvulsive treatment and lithium carbonate. Their effects on norepinephrine metabolism in patients with primary, major depressions.
    Linnoila M, Karoum F, Rosenthal N, Potter WZ.
    Arch Gen Psychiatry; 1983 Jun; 40(6):677-80. PubMed ID: 6221709
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.